342 related articles for article (PubMed ID: 34651581)
21. Endogenous MMP-9 and not MMP-2 promotes rheumatoid synovial fibroblast survival, inflammation and cartilage degradation.
Xue M; McKelvey K; Shen K; Minhas N; March L; Park SY; Jackson CJ
Rheumatology (Oxford); 2014 Dec; 53(12):2270-9. PubMed ID: 24982240
[TBL] [Abstract][Full Text] [Related]
22. Actin cytoskeleton dynamics linked to synovial fibroblast activation as a novel pathogenic principle in TNF-driven arthritis.
Vasilopoulos Y; Gkretsi V; Armaka M; Aidinis V; Kollias G
Ann Rheum Dis; 2007 Nov; 66 Suppl 3(Suppl 3):iii23-8. PubMed ID: 17934089
[TBL] [Abstract][Full Text] [Related]
23. Fibroblast heterogeneity: implications for human disease.
Lynch MD; Watt FM
J Clin Invest; 2018 Jan; 128(1):26-35. PubMed ID: 29293096
[TBL] [Abstract][Full Text] [Related]
24. Transcription factor snail regulates tumor necrosis factor α-mediated synovial fibroblast activation in the rheumatoid joint.
Chen SY; Shiau AL; Li YT; Lin CC; Jou IM; Liu MF; Wu CL; Wang CR
Arthritis Rheumatol; 2015 Jan; 67(1):39-50. PubMed ID: 25303734
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic alterations in rheumatoid arthritis fibroblast-like synoviocytes.
Doody KM; Bottini N; Firestein GS
Epigenomics; 2017 Apr; 9(4):479-492. PubMed ID: 28322585
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic opportunities in fibroblasts in inflammatory arthritis.
Niedermeier M; Pap T; Korb A
Best Pract Res Clin Rheumatol; 2010 Aug; 24(4):527-40. PubMed ID: 20732650
[TBL] [Abstract][Full Text] [Related]
27. Characterization of a SV40-transformed rheumatoid synovial fibroblast cell line which retains genotypic expression patterns: a model for evaluation of anti-arthritic agents.
Zhang HG; Blackburn WD; Minghetti PP
In Vitro Cell Dev Biol Anim; 1997 Jan; 33(1):37-41. PubMed ID: 9028833
[TBL] [Abstract][Full Text] [Related]
28. Intestinal fibrosis in inflammatory bowel disease: progress in basic and clinical science.
Rieder F; Fiocchi C
Curr Opin Gastroenterol; 2008 Jul; 24(4):462-8. PubMed ID: 18622160
[TBL] [Abstract][Full Text] [Related]
29. Synovial cell activation.
Stanczyk J; Ospelt C; Gay RE; Gay S
Curr Opin Rheumatol; 2006 May; 18(3):262-7. PubMed ID: 16582690
[TBL] [Abstract][Full Text] [Related]
30. Synovial Tissue: Cellular and Molecular Phenotyping.
Shanaj S; Donlin LT
Curr Rheumatol Rep; 2019 Aug; 21(10):52. PubMed ID: 31468238
[TBL] [Abstract][Full Text] [Related]
31. Defining a role for fibroblasts in the persistence of chronic inflammatory joint disease.
Buckley CD; Filer A; Haworth O; Parsonage G; Salmon M
Ann Rheum Dis; 2004 Nov; 63 Suppl 2(Suppl 2):ii92-ii95. PubMed ID: 15479882
[TBL] [Abstract][Full Text] [Related]
32. Regulation of fibroblast-like synoviocyte transformation by transcription factors in arthritic diseases.
Bhattaram P; Jones K
Biochem Pharmacol; 2019 Jul; 165():145-151. PubMed ID: 30878552
[TBL] [Abstract][Full Text] [Related]
33. Trikatu, an herbal compound ameliorates rheumatoid arthritis by the suppression of inflammatory immune responses in rats with adjuvant-induced arthritis and on cultured fibroblast like synoviocytes via the inhibition of the NFκB signaling pathway.
Doss HM; Ganesan R; Rasool M
Chem Biol Interact; 2016 Oct; 258():175-86. PubMed ID: 27613480
[TBL] [Abstract][Full Text] [Related]
34. Toll-like receptors expressed by synovial fibroblasts perpetuate Th1 and th17 cell responses in rheumatoid arthritis.
Hu F; Li Y; Zheng L; Shi L; Liu H; Zhang X; Zhu H; Tang S; Zhu L; Xu L; Yang Y; Li Z
PLoS One; 2014; 9(6):e100266. PubMed ID: 24936783
[TBL] [Abstract][Full Text] [Related]
35. Influences of the lncRNA TUG1-miRNA-34a-5p network on fibroblast-like synoviocytes (FLSs) dysfunction in rheumatoid arthritis through targeting the lactate dehydrogenase A (LDHA).
Zhang M; Lu N; Guo XY; Li HJ; Guo Y; Lu L
J Clin Lab Anal; 2021 Sep; 35(9):e23969. PubMed ID: 34403518
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of DNM1L and mitochondrial fission attenuates inflammatory response in fibroblast-like synoviocytes of rheumatoid arthritis.
Wang X; Chen Z; Fan X; Li W; Qu J; Dong C; Wang Z; Ji Z; Li Y
J Cell Mol Med; 2020 Jan; 24(2):1516-1528. PubMed ID: 31755231
[TBL] [Abstract][Full Text] [Related]
37. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis.
Bartok B; Firestein GS
Immunol Rev; 2010 Jan; 233(1):233-55. PubMed ID: 20193003
[TBL] [Abstract][Full Text] [Related]
38. Kinesin-like protein CENP-E is upregulated in rheumatoid synovial fibroblasts.
Kullmann F; Judex M; Ballhorn W; Jüsten HP; Wessinghage D; Welsh J; Yen TJ; Lang B; Hittle JC; McClelland M; Gay S; Schölmerich J; Müller-Ladner U
Arthritis Res; 1999; 1(1):71-80. PubMed ID: 11056662
[TBL] [Abstract][Full Text] [Related]
39. The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis.
Noss EH; Brenner MB
Immunol Rev; 2008 Jun; 223():252-70. PubMed ID: 18613841
[TBL] [Abstract][Full Text] [Related]
40. Differential survival of leukocyte subsets mediated by synovial, bone marrow, and skin fibroblasts: site-specific versus activation-dependent survival of T cells and neutrophils.
Filer A; Parsonage G; Smith E; Osborne C; Thomas AM; Curnow SJ; Rainger GE; Raza K; Nash GB; Lord J; Salmon M; Buckley CD
Arthritis Rheum; 2006 Jul; 54(7):2096-108. PubMed ID: 16802344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
